Skip Header

You are using a version of Internet Explorer that may not display all features of this website. Please upgrade to a modern browser.
Contribute Send feedback
Read comments (?) or add your own

Q13439 (GOGA4_HUMAN) Reviewed, UniProtKB/Swiss-Prot

Last modified July 9, 2014. Version 138. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (6) | Third-party data text xml rdf/xml gff fasta
to top of pageNames·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order

Names and origin

Protein namesRecommended name:
Golgin subfamily A member 4
Alternative name(s):
256 kDa golgin
Golgin-245
Protein 72.1
Trans-Golgi p230
Gene names
Name:GOLGA4
OrganismHomo sapiens (Human) [Reference proteome]
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length2230 AA.
Sequence statusComplete.
Protein existenceEvidence at protein level

General annotation (Comments)

Function

May play a role in delivery of transport vesicles containing GPI-linked proteins from the trans-Golgi network through its interaction with MACF1. Ref.8

Subunit structure

Homodimer. Interacts with GTP bound ARL1. Interacts with MACF1. Ref.7 Ref.8 Ref.16

Subcellular location

Cytoplasm. Golgi apparatus membrane; Peripheral membrane protein. Golgi apparatus Ref.7 Ref.8 Ref.16.

Domain

Extended rod-like protein with coiled-coil domains.

Miscellaneous

Antibodies against GOLGA4 are present in sera from patients with Sjoegren syndrome. Sera from patients with Sjoegren syndrome often contain antibodies that react with normal components of the Golgi complex.

Sequence similarities

Contains 1 GRIP domain.

Sequence caution

The sequence BAD92930.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally shortened.

The sequence CAA58041.1 differs from that shown. Reason: Frameshift at position 2153.

Binary interactions

With

Entry

#Exp.

IntAct

Notes

ANKRD27Q96NW42EBI-1037845,EBI-6125599

Alternative products

This entry describes 4 isoforms produced by alternative splicing. [Align] [Select]

Note: Additional isoforms seem to exist.
Isoform 1 (identifier: Q13439-1)

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
Isoform 3 (identifier: Q13439-3)

The sequence of this isoform differs from the canonical sequence as follows:
     2103-2109: Missing.
Isoform 4 (identifier: Q13439-4)

The sequence of this isoform differs from the canonical sequence as follows:
     2222-2230: FTSPRSGIF → SWLRSSS
Isoform 5 (identifier: Q13439-5)

The sequence of this isoform differs from the canonical sequence as follows:
     54-54: E → ENASTHASKSPDSVNGSEPSIPQ
     2103-2109: Missing.
     2222-2230: FTSPRSGIF → SWLRSSS
Note: No experimental confirmation available.

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 22302230Golgin subfamily A member 4
PRO_0000190059

Regions

Domain2168 – 221548GRIP
Region133 – 20371Interaction with MACF1
Coiled coil133 – 21852053 Potential
Compositional bias252 – 20961845Glu-rich

Amino acid modifications

Modified residue711Phosphoserine Ref.9 Ref.12 Ref.14
Modified residue781Phosphoserine Ref.12
Modified residue891Phosphoserine Ref.9
Modified residue2661Phosphoserine Ref.9 Ref.11 Ref.12 Ref.14
Modified residue22231Phosphothreonine Ref.9

Natural variations

Alternative sequence541E → ENASTHASKSPDSVNGSEPS IPQ in isoform 5.
VSP_044819
Alternative sequence2103 – 21097Missing in isoform 3 and isoform 5.
VSP_004274
Alternative sequence2222 – 22309FTSPRSGIF → SWLRSSS in isoform 4 and isoform 5.
VSP_004275
Natural variant10281Q → K.
Corresponds to variant rs11718848 [ dbSNP | Ensembl ].
VAR_033975
Natural variant15521N → S.
Corresponds to variant rs9840779 [ dbSNP | Ensembl ].
VAR_033976
Natural variant20581R → S.
Corresponds to variant rs11924014 [ dbSNP | Ensembl ].
VAR_049258

Experimental info

Mutagenesis21771Y → A: Loss of Golgi membrane localization. Loss of ARL1-binding. Ref.7 Ref.16
Mutagenesis21771Y → F: No effect. Ref.7 Ref.16
Mutagenesis21811V → A: Abolishes Golgi localization. Ref.16
Mutagenesis21831F → A: Abolishes Golgi localization. Ref.16
Mutagenesis21861M → A: Abolishes Golgi localization. Ref.16
Mutagenesis21931T → A: Abolishes Golgi localization. Ref.16
Mutagenesis21941M → A: Abolishes Golgi localization. Ref.16
Mutagenesis21971V → A: Abolishes Golgi localization. Ref.16
Mutagenesis21981I → A: Abolishes Golgi localization. Ref.16
Mutagenesis22021L → A: Abolishes Golgi localization. Ref.16
Mutagenesis22041F → A: Abolishes Golgi localization. Ref.16
Mutagenesis22121I → A: Abolishes Golgi localization. Ref.16
Sequence conflict1881R → K in AAC51791. Ref.5
Sequence conflict2201Y → H in AAC51791. Ref.5
Sequence conflict2761T → A in AAC51791. Ref.5
Sequence conflict5841K → E in AAC51791. Ref.5
Sequence conflict6281T → A in AAC51791. Ref.5
Sequence conflict6301K → E in AAC51791. Ref.5
Sequence conflict6821K → N in AAC51791. Ref.5

Secondary structure

....... 2230
Helix Strand Turn

Details...

Sequences

Sequence LengthMass (Da)Tools
Isoform 1 [UniParc].

Last modified November 1, 1996. Version 1.
Checksum: 3BB733DB1EA86134

FASTA2,230261,140
        10         20         30         40         50         60 
MFKKLKQKIS EEQQQLQQAL APAQASSNSS TPTRMRSRTS SFTEQLDEGT PNRESGDTQS 

        70         80         90        100        110        120 
FAQKLQLRVP SVESLFRSPI KESLFRSSSK ESLVRTSSRE SLNRLDLDSS TASFDPPSDM 

       130        140        150        160        170        180 
DSEAEDLVGN SDSLNKEQLI QRLRRMERSL SSYRGKYSEL VTAYQMLQRE KKKLQGILSQ 

       190        200        210        220        230        240 
SQDKSLRRIA ELREELQMDQ QAKKHLQEEF DASLEEKDQY ISVLQTQVSL LKQRLRNGPM 

       250        260        270        280        290        300 
NVDVLKPLPQ LEPQAEVFTK EENPESDGEP VVEDGTSVKT LETLQQRVKR QENLLKRCKE 

       310        320        330        340        350        360 
TIQSHKEQCT LLTSEKEALQ EQLDERLQEL EKIKDLHMAE KTKLITQLRD AKNLIEQLEQ 

       370        380        390        400        410        420 
DKGMVIAETK RQMHETLEMK EEEIAQLRSR IKQMTTQGEE LREQKEKSER AAFEELEKAL 

       430        440        450        460        470        480 
STAQKTEEAR RKLKAEMDEQ IKTIEKTSEE ERISLQQELS RVKQEVVDVM KKSSEEQIAK 

       490        500        510        520        530        540 
LQKLHEKELA RKEQELTKKL QTREREFQEQ MKVALEKSQS EYLKISQEKE QQESLALEEL 

       550        560        570        580        590        600 
ELQKKAILTE SENKLRDLQQ EAETYRTRIL ELESSLEKSL QENKNQSKDL AVHLEAEKNK 

       610        620        630        640        650        660 
HNKEITVMVE KHKTELESLK HQQDALWTEK LQVLKQQYQT EMEKLREKCE QEKETLLKDK 

       670        680        690        700        710        720 
EIIFQAHIEE MNEKTLEKLD VKQTELESLS SELSEVLKAR HKLEEELSVL KDQTDKMKQE 

       730        740        750        760        770        780 
LEAKMDEQKN HHQQQVDSII KEHEVSIQRT EKALKDQINQ LELLLKERDK HLKEHQAHVE 

       790        800        810        820        830        840 
NLEADIKRSE GELQQASAKL DVFQSYQSAT HEQTKAYEEQ LAQLQQKLLD LETERILLTK 

       850        860        870        880        890        900 
QVAEVEAQKK DVCTELDAHK IQVQDLMQQL EKQNSEMEQK VKSLTQVYES KLEDGNKEQE 

       910        920        930        940        950        960 
QTKQILVEKE NMILQMREGQ KKEIEILTQK LSAKEDSIHI LNEEYETKFK NQEKKMEKVK 

       970        980        990       1000       1010       1020 
QKAKEMQETL KKKLLDQEAK LKKELENTAL ELSQKEKQFN AKMLEMAQAN SAGISDAVSR 

      1030       1040       1050       1060       1070       1080 
LETNQKEQIE SLTEVHRREL NDVISIWEKK LNQQAEELQE IHEIQLQEKE QEVAELKQKI 

      1090       1100       1110       1120       1130       1140 
LLFGCEKEEM NKEITWLKEE GVKQDTTLNE LQEQLKQKSA HVNSLAQDET KLKAHLEKLE 

      1150       1160       1170       1180       1190       1200 
VDLNKSLKEN TFLQEQLVEL KMLAEEDKRK VSELTSKLKT TDEEFQSLKS SHEKSNKSLE 

      1210       1220       1230       1240       1250       1260 
DKSLEFKKLS EELAIQLDIC CKKTEALLEA KTNELINISS SKTNAILSRI SHCQHRTTKV 

      1270       1280       1290       1300       1310       1320 
KEALLIKTCT VSELEAQLRQ LTEEQNTLNI SFQQATHQLE EKENQIKSMK ADIESLVTEK 

      1330       1340       1350       1360       1370       1380 
EALQKEGGNQ QQAASEKESC ITQLKKELSE NINAVTLMKE ELKEKKVEIS SLSKQLTDLN 

      1390       1400       1410       1420       1430       1440 
VQLQNSISLS EKEAAISSLR KQYDEEKCEL LDQVQDLSFK VDTLSKEKIS ALEQVDDWSN 

      1450       1460       1470       1480       1490       1500 
KFSEWKKKAQ SRFTQHQNTV KELQIQLELK SKEAYEKDEQ INLLKEELDQ QNKRFDCLKG 

      1510       1520       1530       1540       1550       1560 
EMEDDKSKME KKESNLETEL KSQTARIMEL EDHITQKTIE IESLNEVLKN YNQQKDIEHK 

      1570       1580       1590       1600       1610       1620 
ELVQKLQHFQ ELGEEKDNRV KEAEEKILTL ENQVYSMKAE LETKKKELEH VNLSVKSKEE 

      1630       1640       1650       1660       1670       1680 
ELKALEDRLE SESAAKLAEL KRKAEQKIAA IKKQLLSQME EKEEQYKKGT ESHLSELNTK 

      1690       1700       1710       1720       1730       1740 
LQEREREVHI LEEKLKSVES SQSETLIVPR SAKNVAAYTE QEEADSQGCV QKTYEEKISV 

      1750       1760       1770       1780       1790       1800 
LQRNLTEKEK LLQRVGQEKE ETVSSHFEMR CQYQERLIKL EHAEAKQHED QSMIGHLQEE 

      1810       1820       1830       1840       1850       1860 
LEEKNKKYSL IVAQHVEKEG GKNNIQAKQN LENVFDDVQK TLQEKELTCQ ILEQKIKELD 

      1870       1880       1890       1900       1910       1920 
SCLVRQKEVH RVEMEELTSK YEKLQALQQM DGRNKPTELL EENTEEKSKS HLVQPKLLSN 

      1930       1940       1950       1960       1970       1980 
MEAQHNDLEF KLAGAEREKQ KLGKEIVRLQ KDLRMLRKEH QQELEILKKE YDQEREEKIK 

      1990       2000       2010       2020       2030       2040 
QEQEDLELKH NSTLKQLMRE FNTQLAQKEQ ELEMTIKETI NKAQEVEAEL LESHQEETNQ 

      2050       2060       2070       2080       2090       2100 
LLKKIAEKDD DLKRTAKRYE EILDAREEEM TAKVRDLQTQ LEELQKKYQQ KLEQEENPGN 

      2110       2120       2130       2140       2150       2160 
DNVTIMELQT QLAQKTTLIS DSKLKEQEFR EQIHNLEDRL KKYEKNVYAT TVGTPYKGGN 

      2170       2180       2190       2200       2210       2220 
LYHTDVSLFG EPTEFEYLRK VLFEYMMGRE TKTMAKVITT VLKFPDDQTQ KILEREDARL 

      2230 
MFTSPRSGIF 

« Hide

Isoform 3 [UniParc].

Checksum: B401B4C93E612E70
Show »

FASTA2,223260,325
Isoform 4 [UniParc].

Checksum: 9E1B1F1B13A6A218
Show »

FASTA2,228260,951
Isoform 5 [UniParc].

Checksum: EDD8BCB88E02B9A4
Show »

FASTA2,243262,328

References

« Hide 'large scale' references
[1]"Molecular characterization of trans-Golgi p230: a human peripheral membrane protein encoded by a gene on chromosome 6p12-22 contains extensive coiled-coil alpha-helical domains and a granin motif."
Erlich R., Gleeson P.A., Campbell P., Dietzsch E., Toh B.-H.
J. Biol. Chem. 271:8328-8337(1996) [PubMed] [Europe PMC] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ALTERNATIVE SPLICING.
[2]Seelig H.P.
Submitted (NOV-1994) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
[3]"The DNA sequence, annotation and analysis of human chromosome 3."
Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J. expand/collapse author list , Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B., Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H., Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J., Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.
Nature 440:1194-1198(2006) [PubMed] [Europe PMC] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[4]"Homo sapiens protein coding cDNA."
Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S., Ohara O., Nagase T., Kikuno R.F.
Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-1279 (ISOFORM 5).
Tissue: Brain.
[5]"Molecular characterization of golgin-245, a novel Golgi complex protein containing a granin signature."
Fritzler M.J., Lung C.-C., Hamel J.C., Griffith K.J., Chan E.K.L.
J. Biol. Chem. 270:31262-31268(1995) [PubMed] [Europe PMC] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 131-2230.
Tissue: Placenta.
[6]Balague C.
Thesis (1994), Instituto municipal de investigacion medica, Spain
Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 524-672.
Tissue: Gastric fundus.
[7]"ADP-ribosylation factors (ARFs) and ARF-like 1 (ARL1) have both specific and shared effectors: characterizing ARL1-binding proteins."
Van Valkenburgh H., Shern J.F., Sharer J.D., Zhu X., Kahn R.A.
J. Biol. Chem. 276:22826-22837(2001) [PubMed] [Europe PMC] [Abstract]
Cited for: INTERACTION WITH ARL1 AND ARL3, SUBCELLULAR LOCATION, MUTAGENESIS OF TYR-2177.
[8]"Interaction between p230 and MACF1 is associated with transport of a glycosyl phosphatidyl inositol-anchored protein from the Golgi to the cell periphery."
Kakinuma T., Ichikawa H., Tsukada Y., Nakamura T., Toh B.H.
Exp. Cell Res. 298:388-398(2004) [PubMed] [Europe PMC] [Abstract]
Cited for: FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH MACF1.
[9]"A quantitative atlas of mitotic phosphorylation."
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P.
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-71; SER-89; SER-266 AND THR-2223, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
Tissue: Cervix carcinoma.
[10]"Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach."
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.
Anal. Chem. 81:4493-4501(2009) [PubMed] [Europe PMC] [Abstract]
Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
[11]"Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K.
Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-266, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
Tissue: Leukemic T-cell.
[12]"Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."
Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.
Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-71; SER-78 AND SER-266, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
Tissue: Cervix carcinoma.
[13]"Initial characterization of the human central proteome."
Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.
BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract]
Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
[14]"System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation."
Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.
Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-71 AND SER-266, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
[15]"Structural basis for Arl1-dependent targeting of homodimeric GRIP domains to the Golgi apparatus."
Panic B., Perisic O., Veprintsev D.B., Williams R.L., Munro S.
Mol. Cell 12:863-874(2003) [PubMed] [Europe PMC] [Abstract]
Cited for: X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 2170-2221 IN COMPLEX WITH ARL1.
[16]"Structural basis for recruitment of GRIP domain golgin-245 by small GTPase Arl1."
Wu M., Lu L., Hong W., Song H.
Nat. Struct. Mol. Biol. 11:86-94(2004) [PubMed] [Europe PMC] [Abstract]
Cited for: X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 2172-2222 IN COMPLEX WITH ARL1, SUBCELLULAR LOCATION, MUTAGENESIS OF TYR-2177; VAL-2181; PHE-2183; MET-2186; THR-2193; MET-2194; VAL-2197; ILE-2198; LEU-2202; PHE-2204 AND ILE-2212, SUBUNIT.
+Additional computationally mapped references.

Cross-references

Sequence databases

EMBL
GenBank
DDBJ
U41740 mRNA. Translation: AAC50434.1.
X82834 mRNA. Translation: CAA58041.1. Frameshift.
AC097359 Genomic DNA. No translation available.
AB209693 mRNA. Translation: BAD92930.1. Different initiation.
U31906 mRNA. Translation: AAC51791.1.
X76942 mRNA. Translation: CAA54261.1.
CCDSCCDS2666.1. [Q13439-1]
CCDS54564.1. [Q13439-5]
RefSeqNP_001166184.1. NM_001172713.1. [Q13439-5]
NP_002069.2. NM_002078.4. [Q13439-1]
UniGeneHs.344151.

3D structure databases

PDBe
RCSB-PDB
PDBj
EntryMethodResolution (Å)ChainPositionsPDBsum
1R4AX-ray2.30E/F/G/H2172-2222[»]
1UPTX-ray1.70B/D/F/H2170-2228[»]
ProteinModelPortalQ13439.
SMRQ13439. Positions 2172-2222.
ModBaseSearch...
MobiDBSearch...

Protein-protein interaction databases

BioGrid109065. 9 interactions.
IntActQ13439. 8 interactions.
MINTMINT-3027757.
STRING9606.ENSP00000354486.

PTM databases

PhosphoSiteQ13439.

Polymorphism databases

DMDM12643718.

Proteomic databases

MaxQBQ13439.
PaxDbQ13439.
PRIDEQ13439.

Protocols and materials databases

StructuralBiologyKnowledgebaseSearch...

Genome annotation databases

EnsemblENST00000356847; ENSP00000349305; ENSG00000144674. [Q13439-5]
ENST00000361924; ENSP00000354486; ENSG00000144674. [Q13439-1]
GeneID2803.
KEGGhsa:2803.
UCSCuc003cgv.3. human. [Q13439-1]
uc003cgx.3. human. [Q13439-4]

Organism-specific databases

CTD2803.
GeneCardsGC03P037284.
HGNCHGNC:4427. GOLGA4.
HPAHPA035102.
HPA040675.
MIM602509. gene.
neXtProtNX_Q13439.
PharmGKBPA28808.
GenAtlasSearch...

Phylogenomic databases

eggNOGNOG12793.
HOGENOMHOG000112753.
HOVERGENHBG051754.
InParanoidQ13439.
OMANEEYVES.
OrthoDBEOG72C4ZF.
PhylomeDBQ13439.
TreeFamTF325082.

Gene expression databases

ArrayExpressQ13439.
BgeeQ13439.
CleanExHS_GOLGA4.
GenevestigatorQ13439.

Family and domain databases

Gene3D1.10.220.60. 1 hit.
InterProIPR000237. GRIP.
[Graphical view]
PfamPF01465. GRIP. 1 hit.
[Graphical view]
SMARTSM00755. Grip. 1 hit.
[Graphical view]
SUPFAMSSF101283. SSF101283. 1 hit.
PROSITEPS50913. GRIP. 1 hit.
[Graphical view]
ProtoNetSearch...

Other

ChiTaRSGOLGA4. human.
EvolutionaryTraceQ13439.
GeneWikiGOLGA4.
GenomeRNAi2803.
NextBio11049.
PROQ13439.
SOURCESearch...

Entry information

Entry nameGOGA4_HUMAN
AccessionPrimary (citable) accession number: Q13439
Secondary accession number(s): F8W8Q7 expand/collapse secondary AC list , Q13270, Q13654, Q14436, Q59EW8
Entry history
Integrated into UniProtKB/Swiss-Prot: December 1, 2000
Last sequence update: November 1, 1996
Last modified: July 9, 2014
This is version 138 of the entry and version 1 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation programChordata Protein Annotation Program
DisclaimerAny medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.

Relevant documents

SIMILARITY comments

Index of protein domains and families

PDB cross-references

Index of Protein Data Bank (PDB) cross-references

MIM cross-references

Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot

Human polymorphisms and disease mutations

Index of human polymorphisms and disease mutations

Human entries with polymorphisms or disease mutations

List of human entries with polymorphisms or disease mutations

Human chromosome 3

Human chromosome 3: entries, gene names and cross-references to MIM